ArticlePharmaceutics2023

Mitochondrial-Targeted Triphenylphosphonium-Hydroxycamptothecin Conjugate and Its Nano-Formulations for Breast Cancer Therapy: In Vitro and In Vivo Investigation.

Kunfeng Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.